참고문헌
- Ahsan H, Parveen N, Khan NU and Hadi SM. (1999). Prooxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chemico-biological Interactions. 121:161-175. https://doi.org/10.1016/S0009-2797(99)00096-4
- Akira S and Takeda K. (2004). Toll-like receptor signalling. Nature Reviews Immunology. 4:499-511. https://doi.org/10.1038/nri1391
- Ammon HP and Wahl MA. (1991). Pharmacology of Curcuma longa. Planta Medica. 57:1-7. https://doi.org/10.1055/s-2006-960004
- Arrese M, Cabrera D, Kalergis AM and Feldstein AE. (2016). Innate immunity and inflammation in NAFLD/NASH. Digestive Diseases and Sciences. 61:1294-1303. https://doi.org/10.1007/s10620-016-4049-x
- Bacon BR, Farahvash MJ, Janney CG and Neuschwander- Tetri BA. (1994). Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology. 107:1103-1109. https://doi.org/10.1016/0016-5085(94)90235-6
- Bieghs V and Trautwein C. (2003). The innate immune response during liver inflammation and metabolic disease. Trends in Immunology. 34:446-452. https://doi.org/10.1016/j.it.2013.04.005
- Brunt EM. (2002). Alcoholic and nonalcoholic steatohepatitis. Clinics in Liver Disease. 6:399-420. https://doi.org/10.1016/S1089-3261(02)00002-8
- Choi SK. (2004). Growth characteristics of Curcuma longa L. in southern part of Korea. Korean Journal of Medicinal Crop Science. 12:85-88.
- Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E and Szabo G. (2011). Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology. 300:433-441. https://doi.org/10.1152/ajpgi.00163.2009
- Farmer SR. (2006). Transcriptional control of adipocyte formation. Cell Metabolism. 4:263-273. https://doi.org/10.1016/j.cmet.2006.07.001
- Gervois P, Torra IP, Fruchart JC and Staels B. (2000). Regulation of lipid and lipoprotein metabolism by PPAR activators. Clinical Chemistry and Laboratory Medicine. 38:3-11. https://doi.org/10.1515/CCLM.2000.002
- Hardie DG. (2007). AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nature Reviews. Molecular Cell Biology 8:774-785. https://doi.org/10.1038/nrm2249
- Herzig S and Shaw RJ. (2017). AMPK: Guardian of metabolism and mitochondrial homeostasis. Nature Reviews Molecular Cell Biology. 19:121-135. https://doi.org/10.1038/nrm.2017.95
- Kang OH, Kim SB, Seo YS, Joung DK, Mun SH, Choi JG, Lee YM, Kang DG, Lee HS and Kwon DY. (2013). Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells. European Review for Medical and Pharmacological Sciences. 17:2578-2586.
- Kesar V and Odin JA. (2013). Toll-like receptors and liver disease. Liver International. 34:184-196. https://doi.org/10.1111/liv.12315
-
Kim DS, Park SY and Kim JY. (2001). Curcuminoids from Curcuma longa L.(Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from
${\beta}A$ (1-42) insult. Neuroscience Letters. 303:57-61. https://doi.org/10.1016/S0304-3940(01)01677-9 - Kim SB, Kang OH, Lee YS, Han SH, Ahn YS, Cha SW, Seo YS, Kong R and Kwon DY. (2016). Hepatoprotective effect and synergism of bisdemethoycurcumin against MCD dietinduced nonalcoholic fatty liver disease in mice. PLoS One. 11:e0147745. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147745 (cited by 2020 May 11).
- Kiziltas S, Ata P, Colak Y, Mesçi B, Senates E, Enc F, Ulasoglu C, Tuncer I and Oguz A. (2014). TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metabolic Syndrome and Related Disorders. 12:165-170. https://doi.org/10.1089/met.2013.0120
- Lee JH, Oh MW, Jang HD, Lee YJ, Jeong JT and Park CG. (2020). Growth characteristics of turmeric(Curcuma longa L.) germplasms and storage conditions of seed rhizomes. Korean journal of Medicinal Crop Science. 28:47-55. https://doi.org/10.7783/KJMCS.2020.28.1.47
- Lee RG. (1989). Nonalcoholic steatohepatitis: A study of 49 patients. Human Pathology. 20:594-598. https://doi.org/10.1016/0046-8177(89)90249-9
- Lee YJ, Kim AK, Kim OH, Lee CY, Lee HK, Jung SO, Lee SR, Kim HS, Kim IY, Yu IS and Jung K. (2016). Sulfur dioxide, heavy metal and curcumin contents in market-available turmeric(Curcuma longa L.). Korean Journal of Medicinal Crop Science. 24:121-128. https://doi.org/10.7783/KJMCS.2016.24.2.121
- Leevy CM. (1962). Fatty liver: A study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine. 41:249-278. https://doi.org/10.1097/00005792-196209000-00003
- Lu YC, Yeh WC and Ohashi PS. (2008). LPS/TLR4 signal transduction pathway. Cytokine. 42:145-151. https://doi.org/10.1016/j.cyto.2008.01.006
- Musi N. (2006). AMP-activated protein kinase and type 2 diabetes. Current Medicinal Chemistry. 13:583-589. https://doi.org/10.2174/092986706776055724
- O'Neill LAJ and Bowie AG. (2007). The family of five: TIRdomain- containing adaptors in Toll-like receptor signalling. Nature Reviews. Immunology. 7:353-364. https://doi.org/10.1038/nri2079
- Pessayre D, Berson A, Fromenty B and Mansouri A. (2001). Mitochondria in steatohepatitis. Seminars in Liver Disease. 21:57-70. https://doi.org/10.1055/s-2001-12929
- Sahebkar A, Chew GT and Watts GF. (2014). New peroxisome proliferator-activated receptor agonists: Potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert Opinion on Pharmacotherapy. 15:493-503. https://doi.org/10.1517/14656566.2014.876992
- Seki E and Brenner DA. (2008). Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology. 48:322-335. https://doi.org/10.1002/hep.22306
- Tilg H and Moschen AR. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 52:1836-1846. https://doi.org/10.1002/hep.24001
- Viollet B, Guigas B, Leclerc J, Hébrard S, Lantier L, Mounier R, Andreelli F and Foretz M. (2009). AMP-activated protein kinase in there gulation of hepatic energy metabolism: From physiology to therapeutic perspectives. Acta Physiologica. 196:81-98. https://doi.org/10.1111/j.1748-1716.2009.01970.x
- Wanless IR and Lentz JS. (1990). Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology. 12:1106-1110. https://doi.org/10.1002/hep.1840120505
- Weng SY and Schuppan D. (2013). AMPK regulates macrophage polarization in adipose tissue inflammation and NASH. Journal of Hepatology. 58:619-621. https://doi.org/10.1016/j.jhep.2012.09.031
- Yang Q, Huang J, Zhang Y, Wang Q, He X, Feng G, Wang W and Li Z. (2013). Effects of soothing liver and invigorating spleen recipes on the mRNA and protein expression of TLR4 in hepatic tissues of rats with NASH. Journal of Chinese Medicinal Materials. 36:78-84.